Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Energy Secretary Jennifer M. Granholm Highlights Clean Energy Investments on Tour of Exelon Nuclear Plant: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24420/375px-Exelon_Corp_logo.png
Energy Secretary Jennifer M. Granholm Highlights Clean Energy Investments on Tour of Exelon Nuclear Plant


Exelon Corp. (Nasdaq: EXC) hosted U.S. Secretary of Energy Jennifer M. Granholm on a tour of Exelon’s Braidwood Generating Station in Will County to highlight the economic and environmental

Energy Secretary Jennifer M. Granholm Highlights Clean Energy Investments on Tour of Exelon Nuclear Plant: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24420/375px-Exelon_Corp_logo.png
Energy Secretary Jennifer M. Granholm Highlights Clean Energy Investments on Tour of Exelon Nuclear Plant


Exelon Corp. (Nasdaq: EXC) hosted U.S. Secretary of Energy Jennifer M. Granholm on a tour of Exelon’s Braidwood Generating Station in Will County to highlight the economic and environmental

Okta Joins the OpenID Foundation Board to Further Advance Open Identity Standards
Okta Joins the OpenID Foundation Board to Further Advance Open Identity Standards


Okta, Inc. (NASDAQ:OKTA), the leading independent provider of identity, today announced it has joined the OpenID Foundation as a sustaining member. The new board position for Okta follows

European Commission Approves Pfizer’s Cibinqo® (abrocitinib) for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis http://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
European Commission Approves Pfizer’s Cibinqo® (abrocitinib) for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis


Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has approved the 100 mg and 200 mg doses of Cibinqo® (abrocitinib), an oral, once-daily, Janus kinase 1 (JAK1) inhibitor

European Commission Approves Pfizer’s Cibinqo® (abrocitinib) for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis http://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
European Commission Approves Pfizer’s Cibinqo® (abrocitinib) for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis


Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has approved the 100 mg and 200 mg doses of Cibinqo® (abrocitinib), an oral, once-daily, Janus kinase 1 (JAK1) inhibitor

Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.http://www.icatcher.com/wp-content/uploads/2012/04/Symantec.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12176/Symantec.jpg
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.http://www.icatcher.com/wp-content/uploads/2012/04/Symantec.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12176/Symantec.jpg
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
CI Global Asset Management Announces ETF Mergers: https://mms.businesswire.com/media/20201105006022/en/836403/5/CI-F_-_RGB_E.jpg
CI Global Asset Management Announces ETF Mergers


CI Global Asset Management (“CI GAM”) today announced a proposal to merge six exchange-traded funds into other ETFs as part of its continuing strategy to modernize its product lineup.



The

Philip Morris International Appoints Business Accelerator Dessi Temperley to its Board of Directors: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23874/225px-Philip_Morris_International_Logo.svg.png
Philip Morris International Appoints Business Accelerator Dessi Temperley to its Board of Directors


Philip Morris International Inc. (PMI) (NYSE: PM) today announced that on December 6, 2021, its Board of Directors appointed a new member, Ms. Dessislava (“Dessi”) Temperley.



Dessi Temperley is a

Philip Morris International Releases 10-Year Anniversary Report on Agricultural Labor Practices: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23874/225px-Philip_Morris_International_Logo.svg.png
Philip Morris International Releases 10-Year Anniversary Report on Agricultural Labor Practices


Today, in recognition of International Day of Human Rights and the International Year for the Elimination of Child Labor (2021), Philip Morris International Inc. (PMI) (NYSE: PM) publishes its

Aurubis AG: Aurubis AG und Wärme Hamburg GmbH bauen größte Industriewärmeversorgung Deutschlands weiter aus: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23699/Aurubis-Logo.svg.png
Aurubis AG: Aurubis AG und Wärme Hamburg GmbH bauen größte Industriewärmeversorgung Deutschlands weiter aus
Aurubis AG: Aurubis AG und Wärme Hamburg GmbH bauen größte Industriewärmeversorgung Deutschlands weiter aus
Aurubis AG: Aurubis AG and Wärme Hamburg GmbH to further expand Germany's largest industrial heat system: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23699/Aurubis-Logo.svg.png
Aurubis AG: Aurubis AG and Wärme Hamburg GmbH to further expand Germany's largest industrial heat system
Aurubis AG: Aurubis AG and Wärme Hamburg GmbH to further expand Germany's largest industrial heat system
 Nutzung von Data Analytics – Deutschland schließt allmählich zu Europa auf: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
 Nutzung von Data Analytics – Deutschland schließt allmählich zu Europa auf


Deutschland liegt bei der digitalen Transformation und der Nutzung hochentwickelter Analysedienste hinter den meisten europäischen Ländern zurück, gewinnt aber allmählich an Auftrieb, so zwei neue

 Germany Slowly Joins Europe in Adopting Data Analytics: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
 Germany Slowly Joins Europe in Adopting Data Analytics


Germany lags behind most of Europe in digital transformation and the use of advanced analytics services but is gradually gaining momentum, according to two new research reports published today by

Eurofins Enhances Clinical and COVID-19 Testing Offering in Japan Through Acquisition of Genetic Lab Co.,Ltd.: https://mms.businesswire.com/media/20200421005718/en/318625/5/EUROFINS_jpg.jpg
Eurofins Enhances Clinical and COVID-19 Testing Offering in Japan Through Acquisition of Genetic Lab Co.,Ltd.


Eurofins Scientific (EUFI.PA), the global scientific leader in bioanalytical testing and a leader in clinical diagnostics testing, announces a share purchase agreement with Transgenic Inc

EQS-News: Swiss Re vereinbart Verkauf von elipsLife an Swiss Life International und langfristige, durch Rückversicherung gestützte Partnerschaft: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23982/Swiss_Re_2013_logo.svg.png
EQS-News: Swiss Re vereinbart Verkauf von elipsLife an Swiss Life International und langfristige, durch Rückversicherung gestützte Partnerschaft
EQS-News: Swiss Re vereinbart Verkauf von elipsLife an Swiss Life International und langfristige, durch Rückversicherung gestützte Partnerschaft
EQS-News: Swiss Re agrees to sell elipsLife to Swiss Life International and to enter into a long-term partnership supported by reinsurance: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23982/Swiss_Re_2013_logo.svg.png
EQS-News: Swiss Re agrees to sell elipsLife to Swiss Life International and to enter into a long-term partnership supported by reinsurance
EQS-News: Swiss Re agrees to sell elipsLife to Swiss Life International and to enter into a long-term partnership supported by reinsurance
DGAP-News: Stabilus S.A. bestätigt vorläufige Zahlen für GJ2021 und schlägt Dividende von 1,25 € je Aktie vor: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24125/375px-Stabilus_logo.svg.png
DGAP-News: Stabilus S.A. bestätigt vorläufige Zahlen für GJ2021 und schlägt Dividende von 1,25 € je Aktie vor
DGAP-News: Stabilus S.A. bestätigt vorläufige Zahlen für GJ2021 und schlägt Dividende von 1,25 € je Aktie vor
DGAP-News: Stabilus S.A. confirms preliminary figures for FY2021 and proposes dividend of €1.25 per share: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24125/375px-Stabilus_logo.svg.png
DGAP-News: Stabilus S.A. confirms preliminary figures for FY2021 and proposes dividend of €1.25 per share
DGAP-News: Stabilus S.A. confirms preliminary figures for FY2021 and proposes dividend of €1.25 per share
DGAP-News: Carl Zeiss Meditec erzielt Rekordumsatz im Geschäftsjahr 2020/21 http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
DGAP-News: Carl Zeiss Meditec erzielt Rekordumsatz im Geschäftsjahr 2020/21
DGAP-News: Carl Zeiss Meditec erzielt Rekordumsatz im Geschäftsjahr 2020/21
DGAP-News: Record revenue for Carl Zeiss Meditec in fiscal year 2020/21 http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
DGAP-News: Record revenue for Carl Zeiss Meditec in fiscal year 2020/21
DGAP-News: Record revenue for Carl Zeiss Meditec in fiscal year 2020/21
DGAP-News: Record revenue for Carl Zeiss Meditec in fiscal year 2020/21 http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
DGAP-News: Record revenue for Carl Zeiss Meditec in fiscal year 2020/21
DGAP-News: Record revenue for Carl Zeiss Meditec in fiscal year 2020/21
DGAP-News: Carl Zeiss Meditec erzielt Rekordumsatz im Geschäftsjahr 2020/21 http://www.meditec.zeiss.com/C125679E0051C774?Open: CARL ZEISS MEDITEC AG
DGAP-News: Carl Zeiss Meditec erzielt Rekordumsatz im Geschäftsjahr 2020/21
DGAP-News: Carl Zeiss Meditec erzielt Rekordumsatz im Geschäftsjahr 2020/21
Freeport-McMoRan Announces Appointment of Hugh Grant to its Board of Directors: https://assets2.sharewise.com/attachment/file/24463/Freeport_McMoRan.svg.png
Freeport-McMoRan Announces Appointment of Hugh Grant to its Board of Directors


Freeport-McMoRan Inc. (NYSE: FCX) announced today the appointment of Hugh Grant to its Board of Directors.



Mr. Grant is the retired Chairman of the Board and Chief Executive Officer of Monsanto

TechnipFMC Awarded Flexible Pipe Frame Agreements by Petrobras in Brazil: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24460/FMC_Technologies_%28logo%29.png
TechnipFMC Awarded Flexible Pipe Frame Agreements by Petrobras in Brazil


TechnipFMC (NYSE: FTI) (PARIS: FTI) has been awarded three frame agreements by Petrobras (NYSE: PBR) that reaffirm the Company’s leadership position in Brazil’s flexible pipe market – the